GoodRx Holdings, Inc. Class A Common Stock (GDRX)
NASDAQ · Healthcare
GoodRx Holdings, Inc. Class A Common Stock Shareholder Equity 2020–2025
GoodRx Holdings, Inc. Class A Common Stock annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- GoodRx Holdings, Inc. Class A Common Stock shareholder equity as of December 31, 2025: 616.3M, a 14.96% decrease year-over-year.
- GoodRx Holdings, Inc. Class A Common Stock shareholder equity for 2025 were 616.3M, a 14.96% decrease from 2024.
- GoodRx Holdings, Inc. Class A Common Stock shareholder equity for 2024 were 724.7M, a 4.90% decrease from 2023.
- GoodRx Holdings, Inc. Class A Common Stock shareholder equity for 2023 were 762.0M, a 6.49% decrease from 2022.
- GoodRx Holdings, Inc. Class A Common Stock shareholder equity for 2022 were 814.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| GoodRx Holdings, Inc. Class A Common Stock Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $616 |
| 2024 | $725 |
| 2023 | $762 |
| 2022 | $815 |
| 2021 | $832 |
| 2020 | $711 |
GoodRx Holdings, Inc. Class A Common Stock Shareholder Equity — FAQ
GoodRx Holdings, Inc. Class A Common Stock (GDRX) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GDRX's shareholder equity history?
The chart and table above show GoodRx Holdings, Inc. Class A Common Stock's shareholder equity by year and by quarter, including the growth rate.